Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Veracyte (VCYT) Return on Sales (2016 - 2025)

Historic Return on Sales for Veracyte (VCYT) over the last 14 years, with Q3 2025 value amounting to 0.15%.

  • Veracyte's Return on Sales rose 100.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.06%, marking a year-over-year increase of 800.0%. This contributed to the annual value of 0.05% for FY2024, which is 2600.0% up from last year.
  • As of Q3 2025, Veracyte's Return on Sales stood at 0.15%, which was up 100.0% from 0.01% recorded in Q2 2025.
  • Veracyte's Return on Sales' 5-year high stood at 0.15% during Q3 2025, with a 5-year trough of 1.14% in Q1 2021.
  • In the last 5 years, Veracyte's Return on Sales had a median value of 0.1% in 2023 and averaged 0.14%.
  • Its Return on Sales has fluctuated over the past 5 years, first crashed by -7600bps in 2021, then surged by 9300bps in 2022.
  • Veracyte's Return on Sales (Quarter) stood at 0.16% in 2021, then surged by 69bps to 0.05% in 2022, then plummeted by -497bps to 0.29% in 2023, then soared by 115bps to 0.04% in 2024, then soared by 235bps to 0.15% in 2025.
  • Its Return on Sales stands at 0.15% for Q3 2025, versus 0.01% for Q2 2025 and 0.06% for Q1 2025.